Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nociceptor neurons suppress antitumor immunity in breast cancer.

Research square·2026
Same author

Nociceptor neurons shape antiviral immunity.

Journal of neuroinflammation·2026
Same author

Nociceptor neurons control pollution-mediated neutrophilic asthma.

eLife·2026
Same author

Prevalence and factors associated with unsafe abortion among women in reproductive age attending Remera Rukoma Hospital, Rwanda.

Reproductive health·2025
Same author

Mechanochemically-mediated dynamic imine bond conjugation for drug delivery using carbon dots.

Nanoscale·2025
Same author

Basophils activate oncostatin M receptor-expressing vagal sensory neurons.

The Journal of allergy and clinical immunology·2025

Related Experiment Video

Updated: Sep 9, 2025

Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell MSC Spheroids Primed in 3-D Cultures Under Xeno-free Conditions
11:05

Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell MSC Spheroids Primed in 3-D Cultures Under Xeno-free Conditions

Published on: March 18, 2017

12.0K

Mesenchymal stromal cells 2.0: thinking outside the box.

Gabrielle A Mandl1, Malak Lahrichi2, Perla Matar3

  • 1Department of Pharmacology and Physiology, Université de Montréal, Montreal, QC, Canada.

Frontiers in Immunology
|September 5, 2025
PubMed
Summary

Mesenchymal stromal cells (MSCs) can be reprogrammed into antigen-presenting cells (APCs) for cancer vaccines. These MSC-APCs show promise in controlling tumors and offer a new platform for cancer immunotherapy.

Keywords:
antigen-presenting cellscancerimmunotherapymesenchymal stromal cellsvaccine

More Related Videos

Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow
09:53

Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow

Published on: July 15, 2016

8.2K
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.1K

Related Experiment Videos

Last Updated: Sep 9, 2025

Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell MSC Spheroids Primed in 3-D Cultures Under Xeno-free Conditions
11:05

Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell MSC Spheroids Primed in 3-D Cultures Under Xeno-free Conditions

Published on: March 18, 2017

12.0K
Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow
09:53

Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow

Published on: July 15, 2016

8.2K
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.1K

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Mesenchymal stromal cells (MSCs) are versatile progenitor cells known for immunomodulation and tissue regeneration.
  • MSCs possess immunoplasticity, allowing them to adopt either suppressive or inflammatory phenotypes.
  • Their ability to act as antigen-presenting cells (APCs) in a pro-inflammatory state opens avenues for cancer immunotherapy.

Purpose of the Study:

  • To explore the reprogramming of MSCs into APCs for cancer vaccination.
  • To review current methods for generating MSC-derived APCs (MSC-APCs).
  • To discuss the potential of MSC-APCs in immune-oncology.

Main Methods:

  • Genetic reprogramming of MSCs to induce an APC phenotype.
  • Pharmacological reprogramming strategies to generate MSC-APCs.
  • Evaluation of MSC-APCs in preclinical murine models for tumor control.

Main Results:

  • Reprogrammed MSCs effectively function as APCs.
  • MSC-APCs have demonstrated significant tumor control in vivo.
  • Generation of MSC-APCs is linked to reactive oxygen species and endoplasmic reticulum stress.

Conclusions:

  • MSC-APCs represent a promising alternative to dendritic cell-based cancer vaccines.
  • Reprogrammed MSCs offer a scalable and manipulable platform for cancer immunotherapy.
  • Further research into MSC-APC phenotype and mechanisms will advance their clinical application.